These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia. Aziz S; McDonald TO; Gohra H J Heart Lung Transplant; 1995; 14(6 Pt 2):S123-36. PubMed ID: 8719474 [TBL] [Abstract][Full Text] [Related]
3. Transplant vasculopathy: a model for coronary artery disease? Deng MC; Plenz G; Erren M; Wilhelm MJ; Moennig G; Rothenburger M; Baba HA Herz; 2000 Mar; 25(2):95-9. PubMed ID: 10829247 [TBL] [Abstract][Full Text] [Related]
5. Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Vassalli G; Gallino A; Weis M; von Scheidt W; Kappenberger L; von Segesser LK; Goy JJ; Eur Heart J; 2003 Jul; 24(13):1180-8. PubMed ID: 12831811 [TBL] [Abstract][Full Text] [Related]
6. Antibody deposition in rat heart which develops transplant vasculopathy in (donor x recipient) F1 environment. Li Z; Kitagawa-Sakakida S; Horiguchi K; Tori M; Shirakura R Surg Today; 2003; 33(7):509-17. PubMed ID: 14506995 [TBL] [Abstract][Full Text] [Related]
7. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. Ardehali A; Laks H; Drinkwater DC; Ziv E; Drake TA Circulation; 1995 Aug; 92(3):450-6. PubMed ID: 7543379 [TBL] [Abstract][Full Text] [Related]
8. Role of antibody and indirect antigen presentation in transplant-associated coronary artery vasculopathy. Rose ML J Heart Lung Transplant; 1996 Apr; 15(4):342-9. PubMed ID: 8732592 [No Abstract] [Full Text] [Related]
9. [Mechanisms of transplant vasculopathy]. Baron H; Plenz G; Deng MC Dtsch Med Wochenschr; 2004 Oct; 129(41):2193-7. PubMed ID: 15457400 [TBL] [Abstract][Full Text] [Related]
10. Cellular and humoral immunity to vascular endothelium and the development of cardiac allograft vasculopathy. Hosenpud JD; Everett JP; Morris TE; Wagner CR; Shipley GD J Heart Lung Transplant; 1995; 14(6 Pt 2):S185-7. PubMed ID: 8719483 [No Abstract] [Full Text] [Related]
11. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652 [TBL] [Abstract][Full Text] [Related]
12. Recipient origin of neointimal vascular smooth muscle cells in cardiac allografts with transplant arteriosclerosis. Hillebrands J; van den Hurk BM; Klatter FA; Popa ER; Nieuwenhuis P; Rozing J J Heart Lung Transplant; 2000 Dec; 19(12):1183-92. PubMed ID: 11124488 [TBL] [Abstract][Full Text] [Related]
13. In vitro culture of infiltrating lymphocytes from coronary arteries and endomyocardial biopsies: association with graft coronary disease. Kaufman C; Zeevi A; Zerbe T; Keenan R; Kormos R; Griffith B; Hardesty R; Armitage J; Uretsky B; Duquesnoy RJ Transplant Proc; 1991 Feb; 23(1 Pt 2):1142-3. PubMed ID: 1989172 [No Abstract] [Full Text] [Related]
14. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467 [TBL] [Abstract][Full Text] [Related]